COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 140 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $349,000 | -50.7% | 20,008 | -43.4% | 0.00% | -50.0% |
| Q1 2022 | $708,000 | +247.1% | 35,328 | +239.7% | 0.00% | +100.0% |
| Q3 2021 | $204,000 | -19.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | +2.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $247,000 | +20.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +0.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | -28.7% | 10,400 | -51.9% | 0.00% | 0.0% |
| Q2 2019 | $286,000 | +29.4% | 21,600 | +63.6% | 0.00% | 0.0% |
| Q1 2019 | $221,000 | +25.6% | 13,200 | +22.2% | 0.00% | 0.0% |
| Q4 2018 | $176,000 | -20.4% | 10,800 | -18.2% | 0.00% | 0.0% |
| Q3 2018 | $221,000 | -32.8% | 13,200 | -2.2% | 0.00% | -50.0% |
| Q2 2018 | $329,000 | -2.7% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $338,000 | +96.5% | 13,500 | +33.7% | 0.00% | 0.0% |
| Q1 2016 | $172,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |